Gemini Therapeutics, Inc. /DE (GMTX) has 4 open-market insider trades by 3 insiders since 2021. The most active filer is Braden Michael Leonard, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Braden Michael Leonard | 10% Owner | — | 2 | $2.6M | 2022-10-26 |
| Jason Patrick Meyenburg | CEOPres | — | 1 | $246K | 2021-05-14 |
| Brian Piekos | CFO | — | 1 | $145K | 2022-05-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Braden Michael Leonard | 10% | Sell | $47K | 2022-10-26 |
| Braden Michael Leonard | 10% Owner | Buy | $2.6M | 2022-04-11 |
| Jason Patrick Meyenburg | CEO & President | Buy | $246K | 2021-05-14 |
| Brian Piekos | CFO | Buy | $145K | 2021-05-14 |
Companies that share insiders with GMTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.